Histogenics

Developer of restorative cell therapies for orthopedic diseases

placeWaltham, Massachusetts, United States calendar_todayFounded 2000 groups84 employees language histogenics.com

Registered entities

Innovation

24 patent families (18 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 5,772 times.

YearFilings
20125
20139
20146
20152
20167
20176
20184
20193
20204
20213
20222
20232

Investor mix

8 investors on record; lead investors include Sofinnova Investments; 2 have since exited.

Investor typeCountShare
Venture capital338%
Private equity225%
Other / undisclosed338%
Coming soon